Compounds > 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
Page last updated: 2024-10-21

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Abdominal Epilepsy

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with Abdominal Epilepsy in 2 studies

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid: structure given in first source; NMDA receptor antagonist

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Panuccio, G1
Curia, G1
Colosimo, A1
Cruccu, G1
Avoli, M2
Bernasconi, A1
Mattia, D1
Olivier, A1
Hwa, GG1

Other Studies

2 other studies available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Abdominal Epilepsy

ArticleYear
Epileptiform synchronization in the cingulate cortex.
    Epilepsia, 2009, Volume: 50, Issue:3

    Topics: 4-Aminopyridine; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Anticonvulsants; Cortical Synchroniz

2009
Epileptiform discharges in the human dysplastic neocortex: in vitro physiology and pharmacology.
    Annals of neurology, 1999, Volume: 46, Issue:6

    Topics: 4-Aminopyridine; 6-Cyano-7-nitroquinoxaline-2,3-dione; Adolescent; Adult; Anticonvulsants; Cerebral

1999